Business FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S. bydigitalpapertown@gmail.comDecember 21, 2024
Health FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage bydigitalpapertown@gmail.comDecember 19, 2024
Health Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal bydigitalpapertown@gmail.comDecember 18, 2024
Health Healthy Returns: A huge deal to boost Novo Nordisk’s manufacturing is one step closer to closing bydigitalpapertown@gmail.comDecember 11, 2024
Health Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly bydigitalpapertown@gmail.comDecember 11, 2024
Health The weight-loss drug boom has become one of the internet’s biggest scams bydigitalpapertown@gmail.comDecember 8, 2024
Health Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data bydigitalpapertown@gmail.comDecember 5, 2024
Health Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says bydigitalpapertown@gmail.comDecember 5, 2024
Health Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next bydigitalpapertown@gmail.comDecember 5, 2024
Health Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial bydigitalpapertown@gmail.comDecember 4, 2024
